Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
As the largest senior living provider in the country, Brookdale Senior Living (NYSE: BKD) is advancing its industry leadership role through a new national branding and communications initiative beginning today. Brookdale’s campaign is designed to provoke audiences to rethink their views of senior living and to capture the essence of the close relationships formed every day between the company's 80,000 associates and nearly 100,000 residents. As part of the campaign, the company is undertaking a broad range of initiatives to evolve the perception of senior living and demonstrate how innovative approaches and services at Brookdale can transform lives.
“We continue to move forward on our objective to develop the preeminent senior living brand, and we believe this campaign will create a cultural redefinition of the value that an innovative senior living provider can bring to people's lives,” said Will Clark, Brookdale’s senior vice president of strategy and innovation. “Brookdale is bringing new life to the traditional view of senior living. We focus our energy on enabling seniors to live their lives to the fullest – and in doing so changing the myths and perceptions of senior living. As the largest senior living provider in the country, we have the opportunity and I believe the responsibility to lead this conversation.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7646051-brookdale-launches-national-campaign/
A new report on strategic account manager (SAM) compensation found that SAM roles continue to grow in importance. Key indicators include the large percentage of future growth companies expect from their strategic accounts and increased investment that companies are making in their SAM programs. Strategic account management is a company-wide initiative in complex, highly matrixed organizations that focuses on building strong and mutually beneficial relationships with a firm's most important customers and partners.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64374-sama-zs-associates-strategic-account-manager-programs
ADP ®, a leading provider of talent management solutions, today introduced an integrated end-to-end platform designed to enable organizations to acquire, develop and retain top talent, while ensuring that they remain leading performers. Crowning a multi-year strategic development effort to create the industry’s leading integrated talent solution, the new ADP platform leverages advanced learning management tools, insightful learning content from Bersin and Associates, as well as an enterprise competency framework to significantly improve the talent management processes of leading organizations.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56307-adp-launches-new-talent-management-offerings
Nearly three in four American voters (74 percent) favor increasing federal funding for cancer research, according to the results of a new national survey conducted on behalf of the American Association for Cancer Research (AACR). The survey results were released today in conjunction with the AACR’s fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to implement a strategy for providing annual budget increases of at least 7 percent for the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA) in fiscal year 2016 and thereafter.
The national survey, which was conducted by Hart Research Associates and Public Opinion Strategies, shows that five out of every six voters recognize what the AACR Cancer Progress Report 2015 details: that progress is being made against cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613551-aacr-cancer-research-survey/
